Nastro Rosa Anna, Arguelles-Arias Anthony, Ongena Marc, Di Costanzo Amelia, Trifuoggi Marco, Guida Marco, Fickers Patrick
Department of Sciences for the Environment, University Parthenope of Naples, Centro Direzionale Isola C4, 80143, Naples, Italy.
Centre d'Ingenierie des Proteines, Bacterial Physiology and Genetics, Allée de la chimie, Université de Liège, Bat. B6, 4000, Liège, Belgium.
Probiotics Antimicrob Proteins. 2013 Dec;5(4):252-8. doi: 10.1007/s12602-013-9143-1.
The intensive use and misuse of antibiotics over the last decades have generated a strong selective pressure for the emergence of multi-resistant strains and nosocomial infections. Biofilm has been demonstrated as a key parameter in spreading infections, especially in hospitals and healthcare units. Therefore, the development of novel anti-biofilm drugs is actually of the upmost importance. Here, the antimicrobial and antibiofilm activities toward pathogenic microorganisms of a set of non-ribosomal synthesized peptides and polyketides isolated from Bacillus amyloliquefaciens ANT1 culture supernatant are presented.
在过去几十年中,抗生素的大量使用和滥用对多重耐药菌株的出现和医院感染产生了强大的选择压力。生物膜已被证明是感染传播的关键因素,尤其是在医院和医疗单位。因此,开发新型抗生物膜药物实际上至关重要。在此,介绍了从解淀粉芽孢杆菌ANT1培养上清液中分离出的一组非核糖体合成肽和聚酮化合物对致病微生物的抗菌和抗生物膜活性。